Although individuals with severe congenital neutropenia (SCN) receiving granulocyte colony‐stimulating factor (G‐CSF) therapy gain (nearly) physiological levels of neutrophils, they are still prone to infections and periodontal diseases. The gene discussed is CSF3; the disease is periodontal disorder.